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Condie,* Michael A. Pereira,* John R. Meier,* H. Paul
Ringhand,* Merrel Robinson,* and Bruce C. Castot
Five toxicological tests were performed using concentrated drinking water samples collected at a pilot-
scaledrinking watertreatment plant that had streams treatedwith differentdisinfectants (nodisinfectant,
ozone, chlorine dioxide, monochloramine, or chlorine) before treatment with granular activated carbon
(GAC). The toxicological tests used in this study were the Ames Salmonella assay, a subchronic in vivo
toxicity assay in mice, the SENCAR mouse skin initiation-promotion assay, a rat liver foci assay, and the
lung adenoma assay in strain A mice. These tests were conducted to determine the general toxicity and
the mutagenic/carcinogenic potential associated with the use ofdisinfection and/or GAC in the treatment
ofdrinkingwater. The stability ofthemutagenic activity ofthe samples testedwas determined byrepeated
analysis using the Ames Salmonella assay. Results indicated that the samples remained mutagenic for
the duration of the tests.
All the drinking water concentrates (4000 x) prepared by the XAD resin adsorption procedure failed to
provide statistically significant indication of carcinogenic activity in the SENCAR mouse, rat liver foci,
and the lung adenoma assays. However, concentrates of the chlorine, chlorine dioxide, and monochlor-
aminetreatedwatersgaveconsistentmutagenicresponses intheAmesSalmonellaassay. GACwaseffective
for 6 months in removing both the mutagenicity of chlorine-treated water and the potential of water to
become mutagenic when treated with chlorine. In the in vivo, subchronic 30-day toxicity test in mice,
some statistically significant differences in organweights and bodyweights ofanimals exposed to different
concentrates of some of the samples were observed. However, a consistent pattern of these differences
indicating overt toxicity was not detected.
Introduction
Complex mixtures oforganic substances found in sur-
face water and goundwater, as well as wastewaters,
defy complete characterization. The best estimate of
toxicological effects associated with the exposure ofthe
human population to organic chemicals is the result of
biological tests on experimental animals and/or orga-
nisms exposed at levels that ensure probable positive
responses. To facilitate biologicaltestingoforganic con-
taminants in drinking waters, a process of isolation/
concentration is necessary because ofthe large number
of compounds present (both identifiable and nonidenti-
fiable) and their trace occurrence (total organic matter
is generally < 10 mg/L).
For the biological testing of concentrated drinking
waters treated with different disinfectants and/or gran-
ular activated carbon (GAC), a series of toxicological
tests were chosen to indicate the general toxicity and
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mutagenic/carcinogenic activity ofthese waters. These
tests were: the Ames Salmonella assay (1,2), the invivo
toxicity in mice assay, the SENCAR mouse skin initi-
ation-promotion assay (3,4), the rat liver foci assay (5-
7), and the lung adenoma assay in strain A mice (8).
Methods
Sample Collection and Preparation
The concentrated drinking water samples to be used
fortoxicologicaltestingwerecollected andconcentrated
at a pilot-scale drinking water treatment plant in Jef-
ferson Parish, LA. A detailed description ofthe facility
has been previously described (9). The influent stream
was split into five separate process streams as indicated
in Figure 1. These process streams were untreated,
disinfected, using ozone, disinfected with chlorine diox-
ide, disinfected with monochloramine, and disinfected
with chlorine. For this study, the actual sampling sites
were 2, 3, 4, 5, 6, 20 + 21, and 36 as shown in Figure
1.
Disinfection after GAC treatment in the chlorine
stream(samplingsite36)wasaccomplishedbyadjustingMILLER ET AL.
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FIGURE 1. Sampling site schematic of the Jefferson Parish, LA, alternative disinfection pilot plant. (A) denotes actual sampling site.
Table 1. The parameters of each process stream at the Jefferson
Parish pilot plant.
Parameter Value
Sampling flow rate 0.5 gal/min
Disinfectant contact time 120 min
Chlorine residual 1.0 mg/L
Chlorine dioxide residual 0.5 mg/L
Monochloramine residual 2.1 mg/L
Ozone residual 0.5 mg/L
Total organic carbon 3.4 mg/L
the sample to a chlorine residual of 1.0 mg/L. The pa-
rameters of each stream are shown in Table 1. The
contact time for chlorine dioxide, monochloramine, and
chlorine streams was increased from 30 min to 2 hr by
use of a modified 50-gal stainless-steel drum.
Two methods, reverse osmosis (10,11) and macrore-
ticular resin process (12,13), were used to collect and
concentrate organic compounds fromdrinkingwaterbe-
fore toxicological testing.
Reverse Osmosis. By use of a FT-30 reverse os-
mosis membrane and a Nafion cation exchange mem-
brane, 2000 gal ofdrinking water were concentrated in
the field by batch concentration as shown in Figure 2.
In this way, 500 gal were reduced to 10 gal of concen-
trate with concurrent removal of sufficient calcium and
magnesium salts to prevent precipitation. This process
was repeated until a total of40 gal of 50 x concentrate
wasobtained. Figure3 showshowfurtherconcentration
was accomplished inthe laboratory by repeating amod-
ified dialysis desalting process in conjunction with the
usual reverse osmosis process until the salt content was
reduced to
- 0.85% NaCl and a final volume of5 gal of
400 x concentrate was obtained. The final concentrate
was sterile filtered into a sterile, stainless-steel con-
tainer by use of a series of graded filter elements, of
which the last element was a sterile 0.2-,um Poll Ultipor
cartridge.
During the reverse osmosis process two continuing
chemical adjustments were performed as the samples
were being concentrated. These adjustments changed
the pH ofthe water to pH 2 by metering dilute hydro-
chloric acid into each cycle of sample pumped into the
concentrate, and softened the waterby use ofa Donnan
dialysis cation exchange unit (Nafion membrane) with
a sodium chloride stripping solution (11). The temper-
ature ofthe sample and concentrate was maintained at
15°C by using heat exchange coils immersed in chilled
water baths.
Samples fortotal organic carbon (TOC) analysis were
collected at various stages in the reverse osmosis pro-
cess to help monitor the progress of the concentration
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FIGURE 2. Schematic of a typical 50 x batch concentration using reverse osmosis procedure.
temperature monitor
FIGURE 3. Desalting apparatus used in conjunction with reverse
osmosis for workup of field concentrates.
and to determine organic recoveries at different steps
in the procedure.
The initial TOC of influent water was 3.4 mg/L. The
mass recoveries, as indicated in Table 2, during field
concentrations (1-50 x) were generally excellent, and
all recoveries were in the 83% to 118% range. Most of
the measured membrane (Film Tech FT-30) TOC re-
jection values were between 92 and 99%. A significant
reduction ofconcentrate TOC mass was lost during lab-
oratoryworkup ofthe samples (concentratingfrom 50 x
to 400 x).
Macroreticular Resins XAD-2 and XAD-8. By
use of two resin-filled glass columns in series and sub-
sequent elution and concentration, 2000-gal samples of
drinking water were reduced to 2 gal (1000x). The
types of resins used were XAD-2 and XAD-8. Each
resin was cleaned before use (14). The resins were pur-
ified by Soxhlet extraction in three separate organic
solvents (methylene chlorine, acetone, and methanol)
for 24 hr each. A subsample ofthe column material was
then eluted with diethyl ether and the eluate checked
before use forpuritybyusing gaschromatographic (GC)
analysis. No detectable impurities were found, and the
resins were stored at 4°C in methanol until used. An
example of a detailed schematic used in the sample col-
lection at sites 2, 3, 4, 5, 6, and 20 + 21 is shown in
Figure 4. Each glass column (14 x 49 cm) was filled
with 5 L ofcleaned resin. Each column pair was rinsed
Table 2. Mass recoveries and membrane TOC rejections for field and laboratory portions of toxicological sample preparation by
reverse osmosis.'
TOC mass recovery TOC mass recovery
Disinfectant stream Sample (field), % (overall), % Rejection, (field), % Rejection (lab), %
Untreated A 109 37 96 93
B 96 46 99 99
Ozone A 83 48 98 93
B 99 43 99 99
Chlorine dioxide A 100 59 92 85
B 97 45 99 99
Monochloramine A 103 56 95 99
B 96 40 99 99
Chlorine A 118 61 94 96
B 102 38 99 99
aAll samples had same raw water source. Paired samples (A and B) had the same disinfectant but were collected on different dates.
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FIGURE 4. Detailed schematic of sampling at sites 20 and 21 (chlo-
rinated and GAC-filtered water). This figure also represents sam-
pling at sites 2, 3, 4, 5, and 6 but before treatment with GAC.
with 30 gal of water to flush out the methanol before
sample collection. Two thousand gallons ofwater were
processed through the column pairs at a flow rate of 9
to 11 bed volumes/hour (0.4-0.5 gal/min). During the
sample collection process, the pH of the influent was
monitored and maintained at pH 2 by adding hydro-
chloric acid. Uniformity of the acid addition was en-
hancedby anin-line staticmixer. SamplesforTOC anal-
yses were taken at collection increments of0, 500, 1000,
1500, and 2000 gal for each process stream collected at
points A, B, and C as shown in Figure 4. The sampling
schematic ofsite 36, as shown in Figure 5, differed from
the other collected samples in that the chlorine stream
was rechlorinated after GAC treatment and had an ad-
ditional contact time of 120 min before sampling.
An example ofTOC data from these process streams
is shown in Table 3. Approximately 40% of the TOC
was retained by the resins. After sample collection, the
XAD-8 and XAD-2 columns were separated, and each
column was filled with acetone, agitated to completely
wet the resins, and then allowed to soak for 15 min. The
columns were each eluted with three resin bed volumes
of acetone. Each column extract was separately evap-
orated to 4L with Buchler continuous flow flash rotary
evaporator. These acetone samples (approximately 1 gal
from each resin column) were stored at -20°C. The
FIGURE 5. Detailed schematic of sampling at site 36 (rechlorinated
GAC-filtered water).
aqueous content ofthe samples was analyzed to be ap-
proximately 20%.
Immediately before use in toxicity tests, aliquots of
each sample were concentrated an additional 5 times by
Kuderna-Danish apparatus, whereby 10% Emulphor in
water was added in small measured aliquots (to mini-
mize precipitation). Evaporation was continued until all
acetone was evaporated and a sample of2% Emulphor
aqueous solution remained, leaving a concentrate equal
to 4000 x the original water sample.
Results
Testing of Reverse Osmosis Concentrates
Two toxicological tests were performed on drinking
watersamples collected at samplepoints 2, 3, 4, 5, and
Table 3. Typical TOC data by resin process.
TOC sampling TOC, mg/L
porta Ogal 500 gal 1000 gad 1500gal 2000 gal
A 3.6 3.5 3.4 3.4 3.4
B 11.0b 2.2 2.7 2.7 2.5
C 30.0b 1.6 2.0 2.1 1.9
aDesignations refer to Fig. 4.
bResin contaminated with methanol (MeOH) even after prerinse
with 50 gal of water.
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6 (Figure 1) and concentrated (400 x) by reverse os-
mosis process, the Ames Salmonella assay and the in
vivo toxicity assay.
Ames Salmonella Assay. The Ames Salmonella
assay was used as a screening process to determine the
potential carcinogenic activity of the samples. The re-
sults of the Ames assay are shown in Table 4. No in-
dications of a mutagenic response for strains TA 98 or
TA 100 were apparent with any ofthe reverse osmosis
concentrates when tested either in the presence or the
absence of a metabolic activation system (-/+ S9).
In Vivo Toxicity Assay. The subchronic toxicity
of the reverse osmosis samples was evaluated in a 30-
day study using CD-1 mice, 10 males and 10 females
per dose group, in which the aqueous samples were
administered as drinking water in concentrations equal
to the original concentrate (400 x) and one-fourth ofthe
original concentrate (100 x). At the end ofthe exposure
period, a necropsy was performed on each animal to
examine it for gross pathological changes. The results
ofthis study are showninTables 5and 6. Taste aversion
to the reverse osmosis concentrates was not seen in the
study. In fact, significant increases in fluid consumption
were detected in four of the female exposure groups.
Statistically significant differences in the body weights
were found at sacrifice oftwo male and two female ex-
posure groups, butthe differencesinbodyweights were
caused by differences in initial body weights, since the
rate of growth of the mice in each experimental group
was the same throughout the study. Alterations in the
ratios of organ weights to body weights are also de-
picted in Tables 5 and 6. Since these data and necropsy
reports did not reveal any overt, subehronic toxicity,
histopathological examination of major organs was not
performed.
Testing of Macroreticular Resin
Concentrates
Drinkingwatersthat werecollected and concentrated
by the macroreticular resin process were used as sam-
ples for toxicological testing. An outline of these tests
and sample identification is shown in Table 7. As noted,
Table 4. Evaluation of mutagenicity of reverse osmosis concentrates ofJefferson Parish water samples.
His' revertants/platea
TA 98 TA 100
Test compound Dose level -S9 +S9 -S9 +S9
Negative control 24 26 146 135
Positive controls (,ug)
Sodium azide 1 702
2-Nitrofluorene 5 841
2-Aminoanthracene 1 302 587
Reverse osmosis concentrates (mL)
Untreated 0.025 25 30 169 161
0.050 22 29 154 143
0.100 23 31 153 151
0.250 25 30 152 131
0.500 17 26 130 115
1.000 19 28 128 122
Ozone 0.025 29 32 161 160
0.050 21 32 153 148
0.100 24 32 146 132
0.250 25 30 150 151
0.500 20 23 133 126
1.000 22 22 136 113
Monochloramine 0.025 26 36 167 167
0.050 24 37 144 162
0.100 24 37 150 177
0.250 20 39 142 147
0.500 21 29 130 159
1.000 18 27 146 134
Chlorine dioxide 0.025 26 36 171 150
0.050 27 29 146 155
0.100 23 35 159 150
0.250 25 32 143 140
0.500 23 28 150 135
1.000 19 29 130 135
Chlorine 0.025 26 39 185 156
0.050 25 39 159 175
0.100 21 36 162 178
0.250 21 31 147 140
0.500 21 34 144 125
1.000 22 29 135 139
aDuplicate experiments using two plates per dose.
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Table 5. Summary of a 30-day subchronic toxicity study in which CD-1 female mice received various RO concentrates for drinking
water for 4 weeks.a
Final Ratiooforganweightstobodyweight Concentra- Fluid body
Group tion consumed weight Brain Kidney Liver Lung Ovaries Spleen
Ozone 100 x ns ns ns ns ns t I ns
400x T ns ns ns ns ns ns
Chlorine dioxide 100x ns 4 ns ns ns ns ns
400x ns ns ns ns ns ns ns ns
Monochloramine 100 x T 4 I ns 4 ns ns
400 x ns ns ns ns ns ns T ns
Chlorine 100 x ns ns ns ns ns ns ns ns
400x T ns ns ns T ns ns ns
Nondisinfected 100 x ns ns ns ns ns 4 4 ns
400 x ns ns ns ns ns 4 4 4
aDisinfectants were compared to corresponding nondisinfected groups compared to distilled water control group by orthogonal contrasts
following ANOVA. T = statistically significant increase or 4 = statistically significant decrease (p < 0.05). ns = no significant difference.
Table 6. Summary of a 30-day subchronic toxicity study in which CD-1 male mice received various RO concentrations for drinking
water for 4 weeks.a
Final Ratio of organ weights to body weight
Fluid body Spleen/
Group Concentration consumed weight brain Kidney Liver Lung Testes
Ozone 100 x ns ns ns ns ns ns ns
400 x ns ns ns ns 4 ns ns
Chlorine dioxide 100 x ns ns ns ns ns ns ns
400 x ns 4 ns ns ns ns ns
Monochloramine 100 x ns ns ns ns 4 ns
400x ns ns ns 4 4 ns ns
Chlorine 100 x ns ns ns ns ns 4 ns
400x ns 4 ns ns ns 4 4
Nondisinfected 100 x ns ns ns ns 4 ns ns
400 x ns ns ns ns ns ns ns
aDisinfectants were compared to corresponding nondisinfected groups and nondisinfected groups compared to distilled water control group
by orthogonal contrasts following ANOVA. 1 = statistically significant increase or 4 = statistically significant decrease (p < 0.05). ns =
no significant difference.
Table 7. Toxicity testing performed on samples prepared by macroreticular resin process.
Assay performed
Sample description Ames/ Liver Lung SENCAR In vivo
(stream and dates) Salmonella foci adenoma mouse toxicity
July 1983
Nondisinfected X X X X
Chlorine X X X X
December 1983
Nondisinfected X X X X
Ozone X X X X
Chlorine dioxide X X X X
Monochloramine X X X X
Chlorine X X X X
Chlorine + GAC X X X X
Chlorine + GAC rechlorinated X X X X
August 1984
Nondisinfected X X X
Monochloramine X X X
Chlorine X X X
Chlorine + GAC X X x
Chlorine + GAC rechlorinated X X X
all samples tested were collected on three different
dates.
Ames Salmonella Assay. Since all the tests for
toxicity could not be conducted simultaneously, the sta-
bility ofthe toxic potential ofthe samples was evaluated
using bacterial mutagenicity in the Ames assay as an
end point. These data are presented in Figure 6. For
those samples which were initially positive in the Ames
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FIGURE 6. Stability of mutagenic activity in drinking water concentrates as determined by Ames Salmonella assay: (*) chlorine dioxide; (0)
monochloramine; (D) chlorine + GAC + rechlorinated; (A) chlorine.
assay, mutagenicity in both TA 98 and TA 100 strains
was consistently detectable throughout the course of
the toxicological tests when stored at 4°C in 2% Emul-
phor. Some differences in the levels of mutagenicity
were noted, but these differences were probably at-
tributable to between-experiment variability in the as-
say. Although data are not shown, no differences in
mutagenic activity were found when the mutagenic ac-
tivity of samples stored for 4 months in acetone at
-20°C was compared to that of samples stored in 2%
Emulphor at 4°C.
In addition to the stability studies, other samples col-
lected on four different occasions, spanning a period of
14 months were also tested for mutagenicity in the
Ames test. Theresults oftests onthese samplesassayed
without S9 are shown in Table 8. When assayed with
S9, the results of all samples gave fewer revertants/
liter equivalent dose than those without S9. The con-
centrates of untreated and ozone-treated water at all
sample collection dates were nonmutagenic in the Ames
test. Monochloramine- and chlorine-treated water con-
centrates were consistently mutagenic in both TA 98
and TA 100 strains; chlorine-dioxide-treated water was
mutagenic only for strain TA 98. The overall order of
mutagenic activity was chlorine > monochloramine >
chlorine dioxide. Treatment of the chlorine-disinfected
waterwith GAC wasinitially effective inremovingboth
the mutagenicity and the mutagen-forming potential of
the water. After 6 months use, the GAC only partially
removed the mutagen-forming potential but was still
effective in removing the mutagenicity of the water.
The TA 98 data also indicate that after being used for
an extended period (14 months) the GAC may become
ineffective in removing the mutagenicity ofchlorinated
water.
Lung Adenoma Assay. One of the toxicological
testsusedfordeterminingthetumor-initiatingpotential
ofthe concentrated drinking water samples is the mice
lung adenoma assay. Nine concentrated water samples
in 2% Emulphor were tested at two dose levels (4000 x
and 2000x) in both sexes of 6-week-old strain A mice.
The three control groups used were a negative control,
a vehicle control (2% sterile Emulphor), and a positive
control (10 mgurethane/mouse by gavage, single dose).
There were 20 animals pergroup, for atotal of840 mice
in 42 groups. After 2 weeks in quarantine, 0.25 mL of
sample was administered by gavage three times aweek
for 8 weeks with toxicological observations for an ad-
ditional 16 weeks. After lung perfusion, the adenomas
were counted independently by two technicians, and
histological confirmation was performed on 10% of the
positive specimens. The number ofanimals within each
group that had lung adenomas is presented in Table 9.
The positive control animals all had lungadenomas with
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Table 8. Mutagenic activity of organic concentrates of raw and treated Mississippi River water assayed without S9.
His+revertants/L equivalent dosea
6-15-83b 7-6-83b 12-5-83b 8-24-84b
Sample TA 98 TA 100 TA 98 TA 100 TA 98 TA 100 TA 98 TA 100
Nondisinfected ns ns ns ns ns ns ns ns
Ozone ns ns ns ns ns ns
Chlorine dioxide 117 ± 17 ns 142 ± 19 ns 126 ± 39 ns
Monochloramine 291 ± 11 771 ± 42 327 ± 24 794 ± 57 92 ± 12 656 ± 28 ns ns
Chlorine 351 ± 22 1338 ± 57 160 ± 14 912 ± 47 151 ± 21 1746 ± 65 162 ± 15 475 ± 73
Chlorine + GAC ns ns - - ns ns 34 ± 9 ns
Chlorine + GAC ns ns - 90 ± 20 521 ± 35 55 ± 7 213 ± 36
rechlorinated
aValues calculated from the linearportion (initial slope) ofthe dose-response curves. ns = nonsignificant (less than 2-fold above background).
bRefers to the date the samples were collected.
a mean of11.5 adenomas per animal, the vehicle control
had 0.1 adenoma per animal, and all other treated
groups had a mean of
- 0.4 adenoma per animal.
The body weight changes and the mortality data
within the exposure groups and controls gave further
indication that no treatment-related effect was evident
during the study.
SENCARMouseInitiation-PromotionAssay. A
mouse skin initiation-promotion assay of the drinking
water concentrates (4000 x) was conducted in SEN-
CAR mice. Each test sample of 0.5 mL was adminis-
tered orally three times per week for 2 weeks. Two
weeks after the final initiating dose, 1.0 ,Lg of 12-tetra-
decanylphorbal-13-acetate (TPA) in0.2mL acetone was
administered by topical application to the dorsal skin of
1/2 ofthe experimental animals three times per weekfor
20 weeks, whereas the remaining animals received ace-
tone only (0.2 mL/mouse) for the same duration. The
control groups for this study were a vehicle control (2%
Emulphor) and a positive control (urethane at 500 mg/
kg). The data presented in Table 10 represent the skin
tumor incidence at 30 experimental weeks.
The treatment with the vehicle control (2% Emul-
phor) yielded 0.09/9 (Study I), 0.25/25 (Study II), and
0.38/36 (Study III) tumors per animal/animals with tu-
mor. Only the group of animals receiving the chlorine/
GAC exposure had more tumors, at 30 weeks into the
study (0.33/33), than did the corresponding control
group. Thehighbackground activityassociatedwiththe
oral Emulphor treatment, when averaged for the three
studies, is consistent with previous results from this
laboratory. The positive control group (urethane at 500
mg/kg) had 0.9 to 1.4 tumors per animal, whereas re-
sults from earlier studies in this laboratory with the
same oral dose yielded 3.0-3.3 tumors per animal after
30 weeks on study. None of the concentrates of disin-
fectant-treated water induced tumors on the backs of
the mice.
RatLiverFoci Study. The carcinogenic activity
of the organic substances present in the concentrated
drinking water samples was also evaluated in the rat
liver foci assay. This short-term bioassay determines
the ability of the sample to initiate -y-glutamyltrans-
peptidase (GGT)-positive foci (5-7). Ten rats per group
Table 9. Results of lung adenoma assay in strain A mice when tested with two dose levels of concentrated drinking water.
Female Male
2000 x Concentrate 4000 x Concentrate 2000 x Concentrate 4000 x Concentrate
Animals Tumors Animals Tumors Animals Tumors Animals Tumors
Sample description with per with per with per with per
(stream and place) tumors animal tumors animal tumors animal tumors animal
July 1983
Nondisinfected 5/20 0.30 5/19 0.32 1/20 0.05 2/29 0.11
Chlorine 1/20 0.05 5/16 0.38 0/20 0.00 3/20 0.15
December 1983
Nondisinfected 4/20 0.20 3/18 0.17 5/18 0.28 1/17 0.06
Ozone 1/20 0.05 1/15 0.07 7/20 0.40 1/19 0.05
Chlorine dioxide 0/20 0.00 2/17 0.12 3/20 0.15 4/16 0.31
Monochloramine 2/18 0.11 1/13 0.08 3/20 0.20 1/20 0.05
Chlorine 0/19 0.00 1/18 0.06 1/20 0.05 1/20 0.05
Chlorine + GAC 0/20 0.00 1/19 0.05 0/20 0.00 1/19 0.05
Chlorine + GAC
rechlorinated 1/20 0.05 2/19 0.11 2/20 0.15 2/20 0.10
Control (neg.) 1/20 0.05 1/19 0.05
Control (veh.) 1/20 0.05 2/15 0.13
(2% Emulphor)
Control (pos.) 19/19 11.47 20/20 11.55
(10 mg urethane)
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Table 10. Results of mouse skin initiation-promotion assay in SENCAR mice treated with concentrates of alternative disinfectant
solutions.
Promotion
Study Treatment (TPA) No. of animals with tumor, % Total tumors Tumors/animal
I Nondisinfected Yes 5/13 (16) 5 0.16
Nondisinfected No 0/16 (0) 0 0
Ozone Yes 5/31 (16) 5 0.16
Ozone No 0/19 (0) 0 0
Chlorine dioxide Yes 4/34 (12) 5 0.15
Chlorine dioxide No 0/14 (0) 0 0
2% Emulphor Yes 3/35 (9) 3 0.09
2% Emulphor No 0/37 (0) 0 0
Urethane Yes 13/20 (65) 18 0.90
II Monochloramine Yes 6/38 (16) 6 0.16
Monochloramine No 0/20 (0) 0 0
Chlorine Yes 3/40 (8) 3 0.08
Chlorine No 0/19 (0) 0 0
Chlorine/GAC Yes 13/39 (33) 13 0.33
Chlorine/GAC No 0/17 (0) 0 0
2% Emulphor Yes 10/40 (25) 10 0.25
2% Emulphor No 0/39 (0) 0 0
Urethane Yes 14/20 (70) 28 1.40
III Chlorine/GAC/chlorine Yes 5/39 (13) 7 0.18
Chlorine/GAC/chlorine No 0/19 (0) 0 0
Nondisinfected/July Yes 6/38 (16) 6 0.16
Nondisinfected/July No 0/18 (0) 0 0
Chlorine/July Yes 5/40 (13) 5 0.13
Chlorine/July No 0/20 (0) 0 0
2% Emulphor Yes 14/39 (36) 15 0.38
2% Emulphor No 0/39 (0) 0 0
Urethane Yes 13/20 (65) 26 1.30
were used for each ofthe test samples, vehicle control
(2% Emulphor), and positive control (50 mg diethylni-
trosamine/kg body weight). All rats were hepatecto-
mized on day 0 (% partial hepatectomy), and treated 24
hr later by oral administration of the test and control
materials. One week later (day 7), the rats started to
receive 500 ppm sodium phenobarbital in their drinking
water for a total of56 days. All animals were sacrificed
at day 70. Frozen liver sections were prepared for the
histochemical detection and quantitation of GGT foci.
Results of these experiments are shown in Table 11.
None of the concentrates of alternative disinfectant-
treated water initiated an incidence of GGT foci above
that of the vehicle control group. The positive control
diethylnitrosamine (DENA) induced a high incidence of
GGT foci, which indicated that the test was functioning
properly.
In Vivo Toxicity. Five of the prepared concen-
trated samples were used in an in vivo toxicity test.
Two dose levels (4000x and 2000x) of each concen-
trated sample were administered to 10 male and 10 fe-
male CD-1 mice per dose. Each 0.3 mL dose was ad-
ministered via gavage three times per week for a total
of4weeks. Bodyweightswere measured once perweek
for 4 weeks, and mice were observed for gross physical
pathological changes. On day 30, all animals were sac-
rificed, and a gross necropsy was performed. Summary
data from this study are shown in Tables 12 and 13.
Table 12 indicates that few changes were detected in
the chlorine and monochloramine groups when com-
Table 11. Incidence of GGT foci in rats treated with
concentrates of alternative disinfection solutions.
Expt. Sample description (stream)
I Nondisinfected
Monochloramine
Chlorine
Chlorine + GAC
Chlorine + GAC rechlorinated
Control (veh.) (2% Emulphor)
Control (pos.) (50 mg DENA/kg)
II Nondisinfected
Ozone
Chlorine dioxide
Monochloramine
Chlorine
Chlorine + GAC
Chlorine + GAC rechlorinated
Nondisinfected
Chlorine
Control (veh.) (2% Emulphor)
Control (pos.) (50 mg DENA/kg)
Mean + SD no.
N of GGT-foci/cm3
9 150 ± 93
10 121 ± 40
10 140 ± 63
9 46± 46
10 62± 31
9 64± 35
9 2111 ± 246
9 21.0 ± 21.0
10 0.00
7 0.00
10 0.00
10 17.1 ± 17.1
4 0.00
9 3.33 ± 3.33
9 0.00
9 0.00
7 0.00
7 383 ± 97
pared to the corresponding nondisinfected groups.
However, numerous changes were detected when the
toxicity of material passing through "spent" GAC was
evaluated before and after rechlorination. These
changes between the chlorine + GAC ("spent") and
rechlorinated chlorine + GAC ("spent") groups are
shown in Table 13. The specific organ weights to body
weight ratios were larger in the rechlorinated chlorine
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Table 12. Summary of a study in which CD-1 mice received XAD extracts by gavage (0.3 mL, three times weekly for 4 weeks).a
Ratio of organ weights to body weight
Brain/liver/lung/ovaries/
Group Sex Concentration Final body weight testes/spleen Kidney
Nondisinfected M 1000x ns ns ns
M 4000x 4 ns ns
Monochloramine M 1000 x ns ns ns
M 4000x ns ns ns
Chlorine M 1000 x ns ns ns
M 4000x ns ns ns
Nondisinfected F 1000x l ns t
F 4000x 4 ns I
Monochloramine F 1000x ns ns ns
F 4000x ns ns ns
Chlorine F 1000x ns ns ns
F 4000x ns ns ns
aMonochloramine and chlorine groups compared to corresponding high or low nondisinfected groups and nondisinfected groups compared to
corresponding vehicle control groups by Tukey's multiple comparison test following ANOVA. I = statistically significant increase or 4 =
statistically significant decrease (p < 0.05). ns = no significant difference.
+ GAC groups in every instance where significant dif-
ferences were detected.
Discussion
The two methods (reverse osmosis and macroretic-
ular resins) used for the collection and concentration of
these alternative disinfected drinking water samples
have been shown to be reliable in the past when pre-
paring samples for identifying specific constituent or-
ganic compounds. However, the results of this study
suggest that because ofconcentration factor limitations
(maximum 400 x because ofsalt interferences), reverse
osmosis is not agood method forconcentrating drinking
water for use in toxicological testing. These results also
suggest that the concentration of drinking water sam-
ples beyond 4000 x or a better collection/concentration
method is warranted ifthe toxicity and the mutagenic/
carcinogenic activity of trace organic pollutants are to
be detectedingeneralanimaltoxicologicalexperiments.
This is particularly true forthe rat liver foci assay, lung
adenoma assay in strain A mice, and SENCAR mouse
initiation-promotion assay, since these methods have
previously demonstrated their ability to detect the car-
cinogenic activity of complex mixtures.
The subchronic in vivo studies with CD-1 mice were
designed to detect only the overt toxicities of the dis-
infected streams. The extracts produced little, if any,
obvious toxicological effects. Ifsubtle toxicities had oc-
curred, they would not have been detected by the ex-
perimental design. The most significant changes in this
study occurred between the chlorine + GAC and re-
chlorinated chlorine + GAC groups of mice. Appar-
ently, some material passed through the GAC treat-
Table 13. Summary of a study in which CD-1 mice received XAD extracts by gavage (0.3 mL three times weekly for 4 weeks).a
Ratio of organ weights to body weight
Final body Ovaries/
Group Sex Concentration weight Brain/kidney Liver Lung testes Spleen
Chlorine M 1000 x
M 4000x -
Chlorine + GAC M 1000 x nsb nsb nsb nsb nsb
M 4000 x b ns nsb ns ns nsb
Chlorine + GAC M 1000x b nsb b nsb ns ns
rechlorinated M 4000 x nsb ns b 4 ns nsb
Chlorine F 1000 x
F 4000x -
Chlorine + GAC F 1000x nsb ns ns ns 4 ns
F 4000 x ns ns ns ns ns ns
Chlorine + GAC F 1000x Tb ns ns ns 4 ns
rechlorinated F 4000 x ns ns ns ns 4 ns
aEach high and low dose group was compared to others by sex by Tukey's multiple comparison test following ANOVA. T = statistically
significant increase or 4 = statistically significant decrease (p < 0.05). ns = no significant difference when compared to chlorine group.
bIndicates significant differences between chlorine + GAC and chlorine + GAC rechlorinated treatment groups.
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ment that may have exerted a biological effect during
rechlorination. It is not clear why the organ sizes in-
creased in the rechlorinated chlorine + GAC groups.
The most significant results of all tests performed
were those of the Ames Salmonella assay on the con-
centrates derived from the macroreticular resin pro-
cess. This assay demonstrated that the concentrated
samples (in2% Emulphor) remained active withrespect
to mutagenic activity throughout the 15-month exper-
imentalperiod. Thisfindingindicatesthat2% Emulphor
may be used as a long-term storage matrix for concen-
trated aqueous samples. In the Ames Salmonella assay,
the chlorine dioxide-, monochloramine-, and chlorine-
treated water concentrates were consistently muta-
genic. Also, according to the Ames assay, GAC is ef-
fective in removing the mutagenicity of chlorinated
drinking water and the potential of water to become
mutagenic when treated with chlorine. However, after
6 months' use in the chlorine stream, the GAC was only
partially effective inremovingthemutagen-formingpo-
tential but was still effective in removing the mutage-
nicity ofthe water.
The results of these short-term animal toxicological
studies reveal the difficulties in analyzing actual drink-
ing waters for detectable toxic effects.
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